Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Nomic Bio logo — The Protein Profiling Company.

Nomic Bio

The Protein Profiling Company.

Founded 2017 Canada Montreal, Canada 105 employees Series B Total: $60.13M Biotechnology, Health Care +1

General Information

Company Name Nomic Bio
Founded Year 2017
Location Canada Montreal, Canada
Employees 105
Industries Biotechnology, Health Care, Marketing
Funding Stage Series B
Business Model B2B, Platform, DaaS
Revenue Model Service Fee, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Nomic Bio. To contact Nomic Bio, visit nomic.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nomic Bio compare?

A PDF of Nomic Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nomic Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nomic Bio

Nomic Bio, known as "The Protein Profiling Company", was founded in 2017 with a mission to simplify biological measurement and make proteomics accessible, scalable, and routine. Based in Canada, the company operates at the intersection of Biotechnology, Health Care, and Marketing.

Nomic's proprietary nELISA® technology provides large-scale, quantitative, and cost-effective protein data aimed at accelerating drug and biomarker discovery, development, and translation. The end-to-end service offered by Nomic integrates seamlessly into various stages of drug research through flexible content, expert support, and analysis-ready outputs.

The company recently secured a $42.00M Series B funding round on 01 September 2024, showcasing strong investor confidence. Noteworthy investors in this round include Real Ventures, Lux Capital, Amplitude Ventures, SR One, and AVANT BIO. Nomic Bio is well-positioned to make proteomics essential in modern biology.

Business keywords: Protein Profiling, Proteomics, nELISA Technology, Bioengineering, Drug Development, Biomarker Discovery, Quantitative Protein Data, High Throughput Analysis, Life Sciences, Translational Research, End-to-End Proteomics Service, Scalable Biological Solutions, Next-Generation Platforms

Services & Products

Omni 1000 Platform
Proteomics Profiling
Custom Protein Panels
End-to-end Proteomics Services

Target Customers

Research Institutions Biotechnology Companies Pharmaceutical Companies Academic Researchers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $42.00M 5
Real Ventures Lux Capital Amplitude Ventures
Real Ventures, Lux Capital +3
01 Sep 2024
Series A $17.00M 3
Lux Capital Casdin Capital SR One
Lux Capital, Casdin Capital +1
01 Dec 2021
Grant $1.00M -
01 Jul 2020
Seed $130.00K 1
Y Combinator
Y Combinator
01 Mar 2020
Seed Undisclosed 2
2048 Ventures Y Combinator
2048 Ventures, Y Combinator
01 Aug 2019
Spinout Undisclosed 2
McGill University, McGill Research and Innovation
01 Jan 2017

Nomic Bio Alternatives & Competitors

View All Alternatives
Nomic Bio vs
Rapid Novor
Rapid Novor Canada

Decode the immune system by sequencing and quantifying antibody proteins. REmAb®, REpAb®, NovorIg™,...

Series A
56 employees
Biotechnology, Health Care
Nomic Bio vs
Pepscope
Pepscope The Netherlands

Kinome Activity Profiling

Venture round
3 employees
Biotechnology, Health Care
Nomic Bio vs
bit.bio
bit.bio United Kingdom

The Cell Coding Company

Series C
123 employees
Biotechnology, Health Care
View all alternatives

FAQ About Nomic Bio

The Protein Profiling Company.
Nomic Bio was founded in 2017.
Nomic Bio is headquartered in Montreal, Canada.
Nomic Bio operates in Biotechnology, Health Care and Marketing. Its work centres on Protein Profiling, Proteomics, nELISA Technology and Bioengineering. Its customers include Research Institutions, Biotechnology Companies and Pharmaceutical Companies.
Nomic Bio has a B2B, Platform and DaaS business model. Its revenue comes from Service Fee, Usage Based and Tiered Pricing.
Nomic Bio has approximately 105 employees.
Nomic Bio has completed 6 funding rounds, raising a total of $60.13M. The latest funding stage is Series B.
Nomic Bio offers: Omni 1000 Platform, Proteomics Profiling, Custom Protein Panels, End-to-end Proteomics Services.
Top alternatives and competitors to Nomic Bio include Rapid Novor, Pepscope, bit.bio, Cambridge Protein Arrays Ltd., iLOF. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nomic Bio and Rapid Novor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nomic Bio, https://bouncewatch.com/company/nomic-bio, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes